A sample of Semaglutide peptide, manufactured and submitted by THELOBSTERLOVE, was analyzed for purity and content verification. The sample, labeled “THELOBSTER SEMAGLUTIDE,” originated from batch LOB10. Testing was conducted by Janoshik Analytical, an independent pharmaceutical quality control laboratory.
The testing revealed a measured content of 10.78 mg, compared to the common 10 mg label claim. This result reflects a 7.8% overage, suggesting that the vial contains slightly more active ingredient than labeled. The purity was reported at 99.813%, indicating an extremely clean sample with minimal contaminants or related compounds.
The test was both submitted and funded by the manufacturer, TheLobster, which may introduce some level of bias due to possible batch pre-selection. Nevertheless, the findings provide insight into this specific lot’s quality.
Detailed Report
Product Overview
- Manufacturer: THELOBSTERLOVE
- Product Name: THELOBSTER SEMAGLUTIDE
- Active Ingredient: Semaglutide
- Batch Number: LOB10
- Expiration Date: Not listed
- Delivery Method: Injectable peptide vial
Sample Acquisition and Testing
- Task Number: #58297
- Testing Ordered: 10 February 2025
- Sample Received: 20 February 2025
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: TheLobster (Manufacturer)
- Analysis Paid For By: TheLobster (Manufacturer)
Testing Results
| Component/Test | Specification (Label Claim) | Measured Concentration | Accuracy | Variance |
|---|---|---|---|---|
| Semaglutide | 10 mg | 10.78 mg | 107.8% | +7.8% |
| Purity | N/A | 99.813% | — | — |
Verification Details
- Verification URL: https://janoshik.com/tests/58297_PLKH5I23RRV6
Evaluation of Manufacturer Testing
The product exceeded label claim by 7.8%, indicating overdosing, though not to a clinically concerning degree. The high purity (99.813%) indicates good manufacturing standards.
Because the sample was submitted and paid for by the manufacturer, the results should be interpreted with a degree of caution. Manufacturer-funded testing lacks the objectivity of independent sampling, and as such, may not represent production-wide consistency.
Conclusion
The test confirms that THELOBSTER SEMAGLUTIDE delivers 10.78 mg of Semaglutide per vial, exceeding the presumed 10 mg specification. High purity levels further support the quality of the tested batch.
While the findings are favorable, they originate from manufacturer-funded testing, which is less robust than independently funded assessments. Consumers should seek additional reports from third-party testers for broader confidence in consistency.
Disclaimer
This report is shared for harm reduction and educational purposes. Manufacturer-funded lab results can be informative but may carry a bias due to potential batch selection. Consumers are encouraged to cross-reference these findings with independent third-party testing.
SEO Metadata
- SEO Title: THELOBSTER Semaglutide Lab Test Results (Feb 2025) – Verified by Janoshik
- URL Slug: thelobster-semaglutide-lab-report-feb-2025
- Meta Description: Lab analysis of THELOBSTER SEMAGLUTIDE by Janoshik reveals 10.78 mg content and 99.813% purity. Manufacturer-submitted sample from Feb 2025.
